-
May 22, 2024 | 
today.westlaw.com | Eva M. Mathews |Janane Venkatraman
(Reuters) - Admiral Acquisition will buy North American engineering and lab-testing services provider Acuren in a $1.85 billion deal, the blank-check company co-founded by dealmaker Martin E. Franklin said on Wednesday. The deal, which is expected to...
-
May 16, 2024 | 
today.westlaw.com | Eva M. Mathews |Anil D'Silva
(Reuters) - The European Medicines Agency (EMA) on Friday recommended scrapping approval for a drug used to prolong gestation, citing a "possible but unconfirmed" risk of cancer.
-
May 16, 2024 | 
today.westlaw.com | Eva M. Mathews |Shinjini Ganguli |Chizu Nomiyama |Paul Sandle
LONDON (Reuters) -Britain's competition watchdog said on Friday it would not investigate the partnership between Microsoft and Mistral AI, weeks after it invited views on the tie-up.
-
May 13, 2024 | 
gurutrade.com | Eva M. Mathews |Nivedita Bhattacharjee |Rashmi Aich
May 14 (Reuters) - British bank Virgin Money UK warned of a tepid second-half of the year on Tuesday, citing higher costs and lower profit margins due to growing investments, inflationary pressures and stiff competition for deposits.
-
May 13, 2024 | 
businesslive.co.za | Clara Denina |Eva M. Mathews
International News For the first time in its 61-year history, the iconic German sports car gets an electrified engine
-
May 2, 2024 | 
inspectioneering.com | Eva M. Mathews |Shailesh Kuber
A consortium that includes Swiss miner and commodities trader Glencore (GLEN.L) and Indonesia's PT Chandra Asri Pacific is in advanced talks to buy Shell's (SHEL.L) oil refinery and petrochemical units in Singapore, in a deal that could be worth about $1 billion, Bloomberg News reported on Friday.
The parties are working on the details of a transaction that could be announced as soon as the coming weeks, Bloomberg reported, citing people with knowledge of the matter.
-
May 1, 2024 | 
jp.reuters.com | Eva M. Mathews
[１日 ロイター] - 英製薬大手グラクソ・スミスクライン（ＧＳＫ）(GSK.L), opens new tabが１日発表した第１・四半期決算は、１株利益と売上高がいずれもアナリスト予想を上回った。また、呼吸器合胞体ウイルス（ＲＳＶ）ワクチンと特殊なエイズウイルス（ＨＩＶ）ワクチンの旺盛な需要を背景に、通期調整後１株利益予想を従来の６─９％増から８─１０％増に上方修正した。 第１・四半期の１株利益は０．４３１ポンド、売上高は７３億６０００万ポンドで、アナリスト予想はそれぞれ０．３７３ポンドと７０億７０００万ポンドだった。 通期売上高の伸び率は従来予想レンジ５─７％の上限を見込んだ。ただ売上高の伸びは下半期に鈍化するとみている。 エマ・ウォルムズリー最高経営責任者（ＣＥＯ）の戦略はワクチン、がん、感染症と、ＨＩＶ分野における長時間作用型治療薬と予防療法への移行に重点を置いている。この戦略は奏功しており、２０２５年以降、１２種の新薬を投入する準備を進めている。...
-
May 1, 2024 | 
globalbankingandfinance.com | Eva M. Mathews |Maggie Fick
By Eva Mathews and Maggie Fick(Reuters) -GSK raised its full-year profit forecast on Wednesday on strong demand for its common respiratory vaccine and specialty HIV medicines, though it expects sales growth to slow in the second half. CEO Emma Walmsley’s strategy has focussed on vaccines, cancer and infectious diseases and a shift in the company’s HIV focus to long-acting treatment and prevention therapies. The strategy has paid off as GSK gears up for 12 launches from 2025.
-
May 1, 2024 | 
world-today-news.com | Eva M. Mathews |Maggie Fick
By Eva Mathews and Maggie FickMay 1 (Reuters) – GSK raised its full-year profit forecast on Wednesday due to strong demand for its common respiratory vaccine and specialty HIV drugs, although it expects sales growth to slow in the second half. CEO Emma Walmsley’s strategy has focused on vaccines, cancer and infectious diseases, as well as the company’s shift in HIV management towards long-acting treatments and preventative therapies.
-
Apr 30, 2024 | 
msn.com | Eva M. Mathews |Maggie Fick
Microsoft Cares About Your PrivacyMicrosoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and improve our services and ads. If you agree, MSN and Microsoft Bing will personalise the content and ads that you see. You can select ‘I Accept’ to consent to these uses or click on ‘Manage preferences’ to review your options and exercise your right to object to Legitimate Interest where used.
